Literature DB >> 31102789

Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell proliferation and collagen accumulation.

Junyu Lai1, Manqing Ge2, Sikui Shen3, Lu Yang3, Tao Jin3, Dehong Cao3, Hang Xu3, Xiaonan Zheng3, Shi Qiu3, Kunjie Wang3, Qiang Wei3, Hong Li3, Jianzhong Ai4.   

Abstract

Chronic cystitis is characterized by the hyperplasia and fibrosis of the bladder wall as well as attenuated compliance of the bladder. To further unravel its underlying molecular mechanism, the role of NFκB-JMJD3 signaling pathway in cystitis induced bladder fibrosis was investigated. Jmjd3 and Col1/3 expression was detected in a cystitis mouse model that was developed by intraperitoneal injection of cyclophosphamide (CYP). Human bladder smooth muscle cells (hBSMCs) were stimulated in vitro with lipopolysaccharide (LPS), and the cell proliferation and collagen accumulation were detected using EdU, CCK8, flow cytometry, qPCR, western blotting and immunofluorescence assays. Furthermore, the effects of NFκB and JMJD3 on cell proliferation and collagen accumulation were investigated using its selective antagonists, JSH23 and GSK-J4, respectively. CYP induced cystitis significantly increased Jmjd3, Col1 and Col3 expression in the bladder muscle cells. Furthermore, LPS stimulation markedly activated NFκB signaling and elevated JMJD3 expression in hBSMCs, and the activation of NFκB-JMJD3 signaling significantly promoted cell proliferation and collagen accumulation by upregulating CCND1 and COL1/3 expression, respectively. Our study reveals the critical role of NFκB-JMJD3 signaling in cystitis induced bladder reconstruction by regulating hBSMC proliferation and extracellular matrix (ECM) deposition, and these findings provide an avenue for effective treatment of patients with cystitis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder fibrosis; Chronic fibrosis; JMJD3; NFκB; hBSMCs

Year:  2019        PMID: 31102789     DOI: 10.1016/j.bbadis.2019.05.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  5 in total

1.  Triterpenoid CDDO-IM protects against lipopolysaccharide-induced inflammatory response and cytotoxicity in macrophages: The involvement of the NF-κB signaling pathway.

Authors:  Hassan Ahmed; Urooj Amin; Xiaolun Sun; Demetrius R Pitts; Yunbo Li; Hong Zhu; Zhenquan Jia
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-16

2.  Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.

Authors:  Yan Jiang; Chan Xiang; Fan Zhong; Yang Zhang; Liyan Wang; Yuanyuan Zhao; Jiucun Wang; Chen Ding; Li Jin; Fuchu He; Haijian Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 3.  Targeting the epigenome in in-stent restenosis: from mechanisms to therapy.

Authors:  Xi Yang; Yanyan Yang; Junjie Guo; Yuanyuan Meng; Min Li; Panyu Yang; Xin Liu; Lynn Htet Htet Aung; Tao Yu; Yonghong Li
Journal:  Mol Ther Nucleic Acids       Date:  2021-01-26       Impact factor: 8.886

4.  Endothelial Cell-Derived SO2 Controls Endothelial Cell Inflammation, Smooth Muscle Cell Proliferation, and Collagen Synthesis to Inhibit Hypoxic Pulmonary Vascular Remodelling.

Authors:  Xin Liu; Shangyue Zhang; Xiuli Wang; Yuanyuan Wang; Jingyuan Song; Chufan Sun; Guozhen Chen; Guosheng Yang; Yinghong Tao; Yongyan Hu; Dingfang Bu; Yaqian Huang; Junbao Du; Hongfang Jin
Journal:  Oxid Med Cell Longev       Date:  2021-04-17       Impact factor: 6.543

5.  Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.

Authors:  Hua Liang; Benquan Liu; Ying Gao; Jiayi Nie; Shuyun Feng; Wenqiang Yu; Shihong Wen; Xi Su
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.